Benitec Biopharma Inc expected to post a loss of 39 cents a share - Earnings Preview

Benitec Biopharma

09/02/2024 14:19

* Benitec Biopharma Inc  BNTC.OQ   BNTC.O  is expected
to show a
fall in quarterly revenue when it reports  results on February
12 (estimated) for the period ending December 31 2023
    * 
    * ​LSEG's mean analyst estimate for Benitec Biopharma Inc is
for a
loss of 39 cents per share. 
    * The one available analyst rating on the shares is "buy".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Benitec
Biopharma
Inc is $8.00​, above​ its last closing price of $2.82. ​​​

This summary was machine generated February 9 at 14:19 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)